摘要
1964~1993年间共行肝癌切除术600例,其中24例为肝癌切除术后复发再次行肝切除术。男533例,女67例。年龄8~78岁,以40~59岁者居多。AFP阳性率为57.4%,合并肝硬化占84.4%。肝细胞癌占91.6%。肿瘤直径<5cm者130例,占21.7%。600例中,施行规则性肝切除10例,非规则性肝切除590例,包括24例再次肝切除术。本组有29例为肝癌自发性破裂出血后作肝切除术,其中24例即时手术,5例作肿瘤破裂填塞止血后16~41天后再行肝切除术。此外,有13例术前作TAE后再行肝切除术,6例经剖腹探查证实不能切除后,采用多模式治疗,待肿瘤缩小后再作肝切除术。本组术后死亡24例,手术死亡率为4.0%。死因多为肝功能衰竭和上消化道大出血。本组术后的1、3、5、10年生存率分别为61.9%、40.0%、33.0%和29.2%。肿瘤直径≤5cm的1、3、5、10年生存率分别为87.8%、69.4%、54.0%和43.0%。
Abstractcancer(PLC)in ourhospital from 1964 to 1993.Among
them,24 cases underwent second hepatic resection because oftumor
recurrence. The ratio of male to female was 8.0:1.Most of the
patients were 40 to 59years old.and the age ranged from 8 to 78 years
old.The positive rate of AFP was 57.4%(≥400μg/L).of them, 84.4%were
associated with hepatic cirrhosis. Hepatocellular carcinoma
wasverified in 91.6% of these cases. Small tumor(≤ 5cm in diameter)
was found in 130 cases(21.7%).In this series,10 cases underwent
semi-hepatectomy and 590 cases underwentirregular
hepatectomy.Spontaneous rupture of tumor was found In 29 cases. In 13
of 600 cases,hepatectomy was done after transcatheter hepatic
arterial chemoembolization. Six of 600 casesunderwent second stage
hepatectomy because the tumots could not be resected
duringlaparotomy. After multimodality therapy, including tumor
ethanol injection treatment, microwave tumorcoagulation and hepatic
artery chemoembolization, the tumors became small and
Subsequentlyresected. In these 600 cases, 24 cases died within one
month after hepatectomy with a mortalityof 4.0%. The most common
cause of death was hepatic failure. The 1-,3-,5-,10-year
survivalrates were 61. 9%, 40.2%, 33.0%, 29.2%,respectively in the
whole series and 87.8%, 69.4%,54.0%, 43.0%respectively in patients
with small tumor.
出处
《中华肿瘤杂志》
CAS
CSCD
北大核心
1995年第2期125-128,共4页
Chinese Journal of Oncology